BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19258077)

  • 1. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
    Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
    J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
    Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
    Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; IeranĂ² C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
    Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE
    Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of CXCR4/CXCL12 overexpression to lymph node metastasis and chronic inflammation in cervical adenocarcinoma].
    Wei M; Liang LZ; Zhang CQ; Xiong Y; Zhang Y; Shen Y; Li JQ
    Ai Zheng; 2007 Mar; 26(3):298-302. PubMed ID: 17355795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
    Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
    Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
    Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
    BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.
    Vande Broek I; Leleu X; Schots R; Facon T; Vanderkerken K; Van Camp B; Van Riet I
    Haematologica; 2006 Feb; 91(2):200-6. PubMed ID: 16461304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.
    Scala S; Ottaiano A; Ascierto PA; Cavalli M; Simeone E; Giuliano P; Napolitano M; Franco R; Botti G; Castello G
    Clin Cancer Res; 2005 Mar; 11(5):1835-41. PubMed ID: 15756007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis.
    Tsuboi K; Kodera Y; Nakanishi H; Ito S; Mochizuki Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A
    Oncol Rep; 2008 Nov; 20(5):1117-23. PubMed ID: 18949410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
    Iwasa S; Yanagawa T; Fan J; Katoh R
    Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
    Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
    Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
    Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
    Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
    Skov BG; Fischer BM; Pappot H
    Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases.
    Paratore S; Banna GL; D'Arrigo M; Saita S; Iemmolo R; Lucenti L; Bellia D; Lipari H; Buscarino C; Cunsolo R; Cavallaro S
    Cancer Biomark; 2011-2012; 10(2):79-89. PubMed ID: 22430135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B; Dong HP; Holth A; Berner A; Risberg B
    Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
    Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
    Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.